FR2513126B1 - PHARMACEUTICAL FORMULATIONS COMPRISING HUMAN INSULIN AND HUMAN C-PEPTIDE - Google Patents

PHARMACEUTICAL FORMULATIONS COMPRISING HUMAN INSULIN AND HUMAN C-PEPTIDE

Info

Publication number
FR2513126B1
FR2513126B1 FR8214595A FR8214595A FR2513126B1 FR 2513126 B1 FR2513126 B1 FR 2513126B1 FR 8214595 A FR8214595 A FR 8214595A FR 8214595 A FR8214595 A FR 8214595A FR 2513126 B1 FR2513126 B1 FR 2513126B1
Authority
FR
France
Prior art keywords
human
peptide
pharmaceutical formulations
insulin
human insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8214595A
Other languages
French (fr)
Other versions
FR2513126A1 (en
Inventor
Ronald Eugene Chance
Bruce Hill Frank
John Allison Galloway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2513126A1 publication Critical patent/FR2513126A1/en
Application granted granted Critical
Publication of FR2513126B1 publication Critical patent/FR2513126B1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR8214595A 1981-08-27 1982-08-25 PHARMACEUTICAL FORMULATIONS COMPRISING HUMAN INSULIN AND HUMAN C-PEPTIDE Expired FR2513126B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (2)

Publication Number Publication Date
FR2513126A1 FR2513126A1 (en) 1983-03-25
FR2513126B1 true FR2513126B1 (en) 1986-04-18

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8214595A Expired FR2513126B1 (en) 1981-08-27 1982-08-25 PHARMACEUTICAL FORMULATIONS COMPRISING HUMAN INSULIN AND HUMAN C-PEPTIDE

Country Status (20)

Country Link
JP (1) JPS5846024A (en)
AU (1) AU551879B2 (en)
BE (1) BE894185A (en)
CA (1) CA1176158A (en)
CH (1) CH650679A5 (en)
DE (1) DE3232034A1 (en)
DZ (1) DZ452A1 (en)
FR (1) FR2513126B1 (en)
GB (1) GB2104382B (en)
IE (1) IE54119B1 (en)
IL (1) IL66611A0 (en)
IT (1) IT1153182B (en)
LU (1) LU84359A1 (en)
MW (1) MW3882A1 (en)
NL (1) NL192192C (en)
NZ (1) NZ201682A (en)
PH (1) PH19361A (en)
SE (1) SE460334B (en)
ZA (1) ZA826159B (en)
ZW (1) ZW17482A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (en) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt PHARMACEUTICAL AGENT FOR TREATING THE DIABETES MELLITUS
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
AU8175387A (en) * 1986-10-20 1988-05-06 Novo Industri A/S Protamine zinc insulin preparations
IE62879B1 (en) * 1987-02-25 1995-03-08 Novo Nordisk As Novel insulin derivatives
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
EP0303308B1 (en) * 1987-08-14 1991-05-29 Akzo N.V. Preparation for preventing or combating complications in diabetes
SE520392C2 (en) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specific peptides for the treatment of diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
CN101060856B (en) * 2004-11-22 2011-01-19 诺和诺德公司 Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
WO2010033207A1 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of therapeutic peptides
KR20130115086A (en) * 2010-05-17 2013-10-21 세빅스 인코포레이티드 Pegylated c-peptide
CN104220086A (en) 2011-11-17 2014-12-17 塞比克斯股份公司 PEGylated C-peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (en) * 1953-09-08 1958-05-31 British Drug Houses Ltd Process for the production of an insulin preparation with an extended duration of action

Also Published As

Publication number Publication date
NL192192C (en) 1997-03-04
GB2104382B (en) 1984-12-19
ZA826159B (en) 1984-04-25
NL192192B (en) 1996-11-01
AU551879B2 (en) 1986-05-15
DE3232034C2 (en) 1991-04-11
IT1153182B (en) 1987-01-14
IL66611A0 (en) 1982-12-31
AU8759482A (en) 1983-03-03
NZ201682A (en) 1985-08-16
SE460334B (en) 1989-10-02
SE8204873D0 (en) 1982-08-25
JPS5846024A (en) 1983-03-17
DZ452A1 (en) 2004-09-13
MW3882A1 (en) 1984-07-11
GB2104382A (en) 1983-03-09
IE822064L (en) 1983-02-27
IE54119B1 (en) 1989-06-21
IT8223017A0 (en) 1982-08-27
DE3232034A1 (en) 1983-03-10
CH650679A5 (en) 1985-08-15
NL8203315A (en) 1983-03-16
PH19361A (en) 1986-04-02
BE894185A (en) 1983-02-24
FR2513126A1 (en) 1983-03-25
ZW17482A1 (en) 1982-11-17
CA1176158A (en) 1984-10-16
LU84359A1 (en) 1983-02-28
SE8204873L (en) 1983-02-28

Similar Documents

Publication Publication Date Title
PT78732B (en) 13-ALPHA-ALKYLGONANEES THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF
FR2513126B1 (en) PHARMACEUTICAL FORMULATIONS COMPRISING HUMAN INSULIN AND HUMAN C-PEPTIDE
BE894188A (en) PHARMACEUTICAL FORMULATIONS COMPRISING INSULIN AND HUMAN PROINSULIN
IT8324035A0 (en) CEFEM COMPOUNDS WITH PHARMACEUTICAL ACTIVITY AND PROCEDURES FOR THEIR PREPARATION.
GB2106115B (en) Pharmaceutical amides, and preparation, formulations and use thereof
BE894187A (en) PHARMACEUTICAL FORMULATIONS COMPRISING HUMAN INSULIN A HUMAN C-PEPTIDE AND HUMAN PROINSULIN
FR2511866B1 (en) PHARMACEUTICAL FORMULATIONS OF HUMAN PROINSULIN
IT1165553B (en) PHARMACEUTICAL COMPOSITION WITH ANTIATEROSCLEROTIC ACTIVITY AND PROCEDURE FOR ITS PREPARATION
IT8420759A1 (en) COMPOSITION WITH IMPROVED PHARMACEUTICAL ACTIVITY AND ITS USE FOR VETERINARY USES
IT1157306B (en) VACCINE AGAINST HUMAN BRUCELLOSIS AND PROCEDURE FOR ITS PREPARATION
ZA827001B (en) Pharmaceutical amides,and preparation,formulations and use thereof
BE885510A (en) OMNI-POTENT MEDICINE FOR MULTIPLE SCLEROSIS AND ARTERIO-SCLEROSIS THERAPEUTICS
JO1236B1 (en) pharmaceutical formulations comprising human insulin and human c-peptide